SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sim, J. S.
Right arrow Articles by Struthers, A. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sim, J. S.
Right arrow Articles by Struthers, A. D
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man

Justein SN Sim

Division of Medicine & Therapeutics, Ninewells Hospital & Medical School

Colin Farquharson

Division of Medicine & Therapeutics, Ninewells Hospital & Medical School

Allan D Struthers

Division of Medicine & Therapeutics, Ninewells Hospital & Medical School, a.d.struthers{at}dundee.ac.uk

Introduction

Losartan improves stimulated endothelial function in patients with cardiovascular disease, but there are no data to establish whether losartan has this effect in normal man. Furthermore, whether losartan improves basal nitric oxide (NO) activity is controversial. We therefore examined whether treatment with losartan improved basal NO activity in normal, salt-replete man. If so, this would imply that tonic levels of angiotensin II (Ang II) reduce tonic basal levels of NO, even in salt-replete normal man.

Methods

We performed a randomised, placebo-controlled, double-blind crossover study in 24 healthy volunteers, comparing losartan 50 mg daily for one month versus placebo. Brachial artery endothelial function was assessed by bilateral venous occlusion plethysmography, measuring the response to intra-arterial infusions of the endothelial-dependent and endothelial-independent vasodilators, acetylcholine and sodium nitroprusside respectively and the endothelial-dependent vasoconstrictor NG-monomethyl-L-arginine. Results were analysed by multiple analysis of variance and statistical significance was taken as a p value of ≤ 0.05.

Results

Losartan significantly increased the vasoconstriction in response to N G-monomethyl-L-arginine (-37 2% vs. -32+2%, losartan vs. placebo; p=0.05). Losartan improved the vasodilatation response to acetylcholine; however, this result did not reach significance (214+2 0% vs. 174+20%, losartan vs. placebo; p=0.15). Losartan did not affect the response to nitroprusside (172+15% vs. 176+16%, losartan vs. placebo; p=0.84). There was no significant difference in blood pressure between the two study days.

Conclusions

Losartan improves basal NO bioactivity in healthy salt-replete volunteers. Even in salt-replete man, basal Ang II levels exert a tonic effect, which reduces basal NO.

Key Words: losartan • endothelium • nitric oxide • renin angiotensin system • angiotensin II

References

  • Pfeffer MA, Braunwald E., Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992;327:669-77.[Abstract]
  • Van Gilst WH, Kingma H., Peels KH, Dambrink JH, St John Sutton M.Which patient benefits from early ACE inhibition after myocardial infarction? Results of a 1 year serial echocardiographic follow-up from the captopril and thrombolysis study (CATS). J Am Coll Cardiol 1996;8:114-21.
  • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.[Abstract]
  • The Heart Outcomes Prevention Evaluation Study Investigators. Effects of angiotensin-converting enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high risk patients. N Engl J Med 2000;342:145-53.[Abstract/Free Full Text]
  • Benjamin N., Calver A., Collier J., Robinson B., Vallance P., Webb DJ Measuring Forearm Blood Flow and Interpreting the Responses to Drugs and Mediators.Hypertension 1995;25:918-23.[Abstract/Free Full Text]
  • Nakamura M., Funakoski T.,Yoshida H.,Arakawa H., Suzuki T., Hiramori K. Endothelium dependent vasodilatation is augmented by angiotensin-converting enzyme inhibitors in healthy volunteers. J Cardiovasc Pharmacol 1992;20:949-54.[Web of Science][Medline] [Order article via Infotrieve]
  • Butler R., Morris AD, Struthers AD Lisinopril improves endothelial function in chronic cigarette smokers. Clin Sci (Lond) 2002;101(1):53-8.
  • O'Driscoll G., Green D., Rankin J., Stanton K., Taylor R. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997;100:678-84.[Web of Science][Medline] [Order article via Infotrieve]
  • Hirooka Y., Imaizumi H., Masaki S. et al. Captopril improves impaired endothelium dependent vasodilatation in hypertensive patients. Hypertension 1992;20:175-80.[Abstract/Free Full Text]
  • Mancini GBJ, Henry GC, Macaya C. et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. (TREND) Circulation 1996;94:258-65.
  • Drexler H., Kurz M., Jeserich T., Munzel T.,Harnig B. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with heart failure. Am J Cardiol 1995; 76:13E-18E.[CrossRef][Medline] [Order article via Infotrieve]
  • Griendling KK, Minieri CA, Ollerenshaw JA, Alexander RW Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.[Abstract/Free Full Text]
  • Berkenboom G. Bradykinin and the therapeutic actions of angiotensin-converting enzyme inhibitors. Am J Cardiol 1998; 82:11S-13S.[Web of Science][Medline] [Order article via Infotrieve]
  • Hornig B., Kohler C., Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997;76:3E-12E.
  • Cheetham C., Collis J., O'Driscoll G., Stanton K., Taylor R., Green D. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. JAm Coll Cardiol 2000;36:1461-6.[Abstract/Free Full Text]
  • Ghiadoni L., Virdis A., Magagna A., Taddei S., Salvetti A. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension 2000;35:501-06.[Abstract/Free Full Text]
  • Prasad A., Narayanan S., Mincemoyer R., Tupas- A. Habib T., Ellahham S., Quyyumi AA Acute and long term effects of angiotensin type 1 receptor inhibition on endothelial dysfunction in atherosclerosis. Circulation 1998;98:I-607.
  • Hornig B., Landmesser U., Kohler C. et al. Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary heart disease. Circulation 2001;103:799-805.[Abstract/Free Full Text]
  • Davidson NC, Barr CS, Struthers AD C-type natriuretic peptide: an endogenous inhibitor of vascular Cangiotensin-converting enzyme activity. Circulation 1996;93:1155-9.[Abstract/Free Full Text]
  • Moncada S., Radomski MW, Palmer RM. Endothelium derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988;37:2495-501.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Feelisch M., Noack E. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987;139:19-30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Greenfield ADM, Paterson GC Reactions of the blood vessels of the human forearm to increases in transmural pressure. J Physiol (Lond) 1954;125:508-24.[Free Full Text]
  • Whitney RJ The measurement of volume changes in human limbs. J Physiol (Lond) 1953;121:1-27.[Free Full Text]
  • Kurland L., Melhus H., Sarabi M., Millgard J., Ljunghall S., Lind L. Polymorphisms in the renin-angiotensin system and endothelium-dependent vasodilation in normotensive subjects. Clin Physiol 2001;21:343-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Butler R., Morris A., Burchall B., Struthers AD The DD ACE genotype polymorphism is associated with endothelial dysfunction in normal man. Hypertension 1999;33:1169-74.[Abstract/Free Full Text]
  • Perticone F., Ceravolo R., Pujia A. et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001;104:191-6.[Abstract/Free Full Text]
  • Suwaidi JA, Hamasaki S., Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long term follow up of patients with mild coronary disease and endothelial dysfunction. Circulation 2000;101:948-54.[Abstract/Free Full Text]
  • Schachinger V., Britten MB, Zeiher AM Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101: 1899-906.[Abstract/Free Full Text]
  • Egashira K., HirookaY, Kai H. et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolaemia. Circulation 1994;89: 2519-24.[Abstract/Free Full Text]
  • Farquharson C., Struthers AD Spironolactone increases NO bioactivity, improves endothelial vasodilator dysfunction and suppresses vascular AI/AII conversion in patients with CHF. Circulation 2000;101:594-7.[Abstract/Free Full Text]
  • Gilligan DM, Sack MN, Guetta V. et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolaemia. J Am Coll Cardiol 1994;24:1611-17.[Abstract]
  • Vusuiku F. Effects of vitamin E on the endothelium: equivocal? -tocopheral and endothelial dysfunction. Cardiovasc Res 2001;51:198-201.[Free Full Text]
  • Muhlen BV, Millgard J., Lind L. Effects of digoxin, furosemide, enalaprilat and metoprolol on endothelial function in young normotensive subjects. Clin Exp Pharmacol Physiol 2001;28:381-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Millgard J., Lind L. Divergent effects of different antihypertensive drugs on endothelium-dependent vasodilation in the human forearm. J Cardiovasc Pharmacol 1998;32:406-12.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Antony I., Lerebours G., Nitenburg A. Angiotensin converting enzyme inhibition restores flow dependent and cold pressor test induced dilations in coronary arteries of hypertensive patients. Circulation 1996;94:3115-22.[Abstract/Free Full Text]
  • Dahlof B., Devereux RB, Kjeldsen SE et al.The LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359: 995-1003.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rajagopalan S., Kurz S., Munzel T. et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.[Web of Science][Medline] [Order article via Infotrieve]
  • Beckman JS, Beckman TW, Chen J. Marshall PA, Freeman BA Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.[Abstract/Free Full Text]
  • Leeuwenburgh C., Hardy MM, Hazen SL et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 1997; 272:1433-6.[Abstract/Free Full Text]
  • Harrison DG Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997;100:2153-7.[Web of Science][Medline] [Order article via Infotrieve]
  • Dijkhorst-Oei LT, Stroes ES, Koomans HA, Rabelink TJ Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J Cardiovasc Pharmacol 1999;33:420-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • HeitzerT., Just H., Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94(1):6-9.[Abstract/Free Full Text]
  • Ting HH,Timimi FK, Boles KS, Creager SJ, Ganz P., Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97(1):22-8.[Web of Science][Medline] [Order article via Infotrieve]
  • Ting HH,Timimi FK, Haley EA, Roddy MA, Ganz P., Creager MA Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolaemia. Circulation 1997;95:2617-22.[Abstract/Free Full Text]
  • Taddei S., Virdis A., Ghiadoni L., Magagna A., Salvetti A.l. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222-9.[Abstract/Free Full Text]
  • Hornig B., Arakawa N., Kohler C., Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;97:363-8.[Abstract/Free Full Text]
  • Gokce N., Keaney JF Jr, Frei B. et al. Long-term ascorbic acid administration reverses endothelial dysfunction in patients with coronary artery disease. Circulation 1999;99:3234-40.[Abstract/Free Full Text]
  • Searles CD, Harrison DG The interaction of nitric oxide, bradykinin and the angiotensin II type 2 receptor: lessons learned from transgenic mice. J Clin Invest 1999;104:1013-14.[Web of Science][Medline] [Order article via Infotrieve]
  • Tsutsumi Y., Matsubara H., Masaki H. et al. Angiotensin II type 2 ocerexpression activates the vascular kinin system and causes vasodilatation. J Clin Invest 1999;104:925-35.[Web of Science][Medline] [Order article via Infotrieve]
  • Warnholtz A., Nickenig G., Schulz E. et al. Increased NADHoxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for the involvement of the renin-angiotensin system. Circulation 1999;99:2027-33.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 5, No. 2, 84-88 (2004)
DOI: 10.3317/jraas.2004.015
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sim, J. S.
Right arrow Articles by Struthers, A. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sim, J. S.
Right arrow Articles by Struthers, A. D
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement